African-American
Men Benefit from Early Detection and TreatmentAfrican-American
men tend to develop more virulent prostate cancer. Evidence from Duke
University for screening and early detection finds that African Americans
with organ-confined disease respond to surgery as well as white men
with the same stage and type of disease.

Low
Level of p27 Predicts Aggressive Prostate Cancer
If prostate cancer patients could be tested to find out how aggressive
their cancer might be, they and their doctors could make much better
choices about the type of treatment likely to be most effective. A protein
pinpointed recently may help do just that  predict whether a given
prostate tumor might grow and spread quickly, or take a slower course.

New
Vaccine in Early Tests on Prostate Cancer Patients
A new vaccine for prostate cancer made at the Sloan-Kettering Institute
for Cancer Research is being given to patients who have had prostate
cancer surgery. The aim is to ward off a recurrence.This is the first
synthetic vaccine to target carbohydrates on the surface of tumor cells.

Angiostatin
Plus Radiation Adding low doses of angiostatin to standard
radiation therapy dramatically improves the response to cancer treatment
in animal models without increasing toxicity, say researchers at the
University of Chicago.

Experienced
Surgeons Save Lives One of the first questions a prostate
cancer patient who is considering surgery should ask his surgeon is,
"How often do you perform this procedure?" That question should
be followed up with, "How often is the procedure performed in this
hospital?"

New
Cancer Gene, Bcl-10 U. K. scientists have found a new gene
mutation, in Bcl-10, which plays a key role in metastasis of common
forms of cancer. We link to Cell, BBC News, and to recent work on the
p53 gene in prostate cancer.